Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Synovial perfusion assessed by dynamic contrast-enhanced MRI is associated to treatment response, remission, and cartilage quality in rheumatoid arthritis.

Sewerin P, Schleich C, Brinks R, Müller-Lutz A, Fichter F, Eichner M, Schneider M, Ostendorf B, Vordenbäumen S.

J Rheumatol. 2019 Mar 15. pii: jrheum.180832. doi: 10.3899/jrheum.180832. [Epub ahead of print]

PMID:
30877219
2.

Projected number of people with diagnosed Type 2 diabetes in Germany in 2040.

Tönnies T, Röckl S, Hoyer A, Heidemann C, Baumert J, Du Y, Scheidt-Nave C, Brinks R.

Diabet Med. 2019 Jan 19. doi: 10.1111/dme.13902. [Epub ahead of print]

PMID:
30659656
3.

The value of the simplified RAMRIS-5 in early RA patients under methotrexate therapy using high-field MRI.

Frenken M, Schleich C, Brinks R, Abrar DB, Goertz C, Schneider M, Ostendorf B, Sewerin P.

Arthritis Res Ther. 2019 Jan 14;21(1):21. doi: 10.1186/s13075-018-1789-3.

4.

Comprehensive longitudinal surveillance of the IgG autoantibody repertoire in established systemic lupus erythematosus.

Vordenbäumen S, Brinks R, Hoyer A, Fischer-Betz R, Pongratz G, Lowin T, Zucht HD, Budde P, Bleck E, Schulz-Knappe P, Schneider M.

Arthritis Rheumatol. 2018 Nov 26. doi: 10.1002/art.40788. [Epub ahead of print]

PMID:
30474930
5.

Illness-Death Model in Chronic Disease Epidemiology: Characteristics of a Related, Differential Equation and an Inverse Problem.

Brinks R.

Comput Math Methods Med. 2018 Sep 12;2018:5091096. doi: 10.1155/2018/5091096. eCollection 2018.

6.

Prevalence and incidence of psoriasis and psoriatic arthritis.

Sewerin P, Brinks R, Schneider M, Haase I, Vordenbäumen S.

Ann Rheum Dis. 2019 Feb;78(2):286-287. doi: 10.1136/annrheumdis-2018-214065. Epub 2018 Sep 21. No abstract available.

PMID:
30242033
7.

Considerations in Epidemiologic Definitions of Undiagnosed Diabetes.

Geiss LS, Bullard KM, Brinks R, Gregg EW.

Diabetes Care. 2018 Sep;41(9):1835-1838. doi: 10.2337/dc17-1838.

PMID:
30135196
8.

Medical adherence in patients with systemic lupus erythematosus in Germany: predictors and reasons for non-adherence - a cross-sectional analysis of the LuLa-cohort.

Chehab G, Sauer GM, Richter JG, Brinks R, Willers R, Fischer-Betz R, Winkler-Rohlfing B, Schneider M.

Lupus. 2018 Sep;27(10):1652-1660. doi: 10.1177/0961203318785245. Epub 2018 Jul 18.

PMID:
30020020
9.

Excess mortality for people diagnosed with type 2 diabetes in 2012 - Estimates based on claims data from 70 million Germans.

Tönnies T, Hoyer A, Brinks R.

Nutr Metab Cardiovasc Dis. 2018 Sep;28(9):887-891. doi: 10.1016/j.numecd.2018.05.008. Epub 2018 May 29.

PMID:
29960839
10.

Vaccination coverage in systemic lupus erythematosus-a cross-sectional analysis of the German long-term study (LuLa cohort).

Chehab G, Richter JG, Brinks R, Fischer-Betz R, Winkler-Rohlfing B, Schneider M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1439-1447. doi: 10.1093/rheumatology/key120.

PMID:
29757414
12.

Rheumatoid Arthritis Magnetic Resonance Imaging Score Predicts Therapy Response: Results of the German ArthroMark Cohort.

Sewerin P, Le L, Vordenbäumen S, Schleich C, Sengewein R, Brinks R, Pongratz G, Bleck E, Lesch J, Mansmann U, Schneider M, Ostendorf B.

J Rheumatol. 2018 Jun;45(6):753-759. doi: 10.3899/jrheum.170797. Epub 2018 Apr 1.

PMID:
29606664
13.

Possible trends in incidence of diabetes in Italy.

Hoyer A, Tönnies T, Brinks R.

Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):427-428. doi: 10.1016/j.numecd.2018.01.009. Epub 2018 Feb 1. No abstract available.

PMID:
29501447
14.

All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany.

Röckl S, Brinks R, Baumert J, Paprott R, Du Y, Heidemann C, Scheidt-Nave C.

BMJ Open Diabetes Res Care. 2017 Dec 16;5(1):e000451. doi: 10.1136/bmjdrc-2017-000451. eCollection 2017. Erratum in: BMJ Open Diabetes Res Care. 2017 Dec 28;5(1):e000451corr1.

15.

Trends in type 2 diabetes detection among adults in the USA, 1999-2014.

Geiss LS, Bullard KM, Brinks R, Hoyer A, Gregg EW.

BMJ Open Diabetes Res Care. 2018 Jan 12;6(1):e000487. doi: 10.1136/bmjdrc-2017-000487. eCollection 2018.

16.

Illness-death model: statistical perspective and differential equations.

Brinks R, Hoyer A.

Lifetime Data Anal. 2018 Oct;24(4):743-754. doi: 10.1007/s10985-018-9419-6. Epub 2018 Jan 27.

PMID:
29374340
17.

Inconsistency between Danish incidence and prevalence data about psoriatic arthritis (PsA).

Sewerin P, Hoyer A, Schneider M, Ostendorf B, Brinks R.

Ann Rheum Dis. 2018 Jan 2. pii: annrheumdis-2017-212817. doi: 10.1136/annrheumdis-2017-212817. [Epub ahead of print] No abstract available.

PMID:
29295824
18.

High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus.

Vordenbäumen S, Böhmer P, Brinks R, Fischer-Betz R, Richter J, Bleck E, Rengers P, Göhler H, Zucht HD, Budde P, Schulz-Knappe P, Schneider M.

Rheumatology (Oxford). 2018 Mar 1;57(3):533-537. doi: 10.1093/rheumatology/kex462.

PMID:
29267954
19.

Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.

Richter JG, Muth T, Li J, Brinks R, Chehab G, Koch T, Siegrist J, Angerer P, Huscher D, Schneider M.

J Rheumatol. 2018 Feb;45(2):227-234. doi: 10.3899/jrheum.170233. Epub 2017 Nov 15.

PMID:
29142037
20.

Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in Germany.

Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W.

Diabetes Care. 2017 Dec;40(12):1703-1709. doi: 10.2337/dc17-0954. Epub 2017 Oct 9.

PMID:
28993421
21.

Important but incomplete data analysis?

Sewerin P, Hoyer A, Schneider M, Ostendorf B, Brinks R.

Ann Rheum Dis. 2018 Apr;77(4):e18. doi: 10.1136/annrheumdis-2017-211979. Epub 2017 Jul 14. No abstract available.

PMID:
28710098
22.

Performance of Antinuclear Antibodies for Classifying Systemic Lupus Erythematosus: A Systematic Literature Review and Meta-Regression of Diagnostic Data.

Leuchten N, Hoyer A, Brinks R, Schoels M, Schneider M, Smolen J, Johnson SR, Daikh D, Dörner T, Aringer M, Bertsias G; Systemic Lupus Erythematosus Classification Criteria Steering Committee.

Arthritis Care Res (Hoboken). 2018 Mar;70(3):428-438. doi: 10.1002/acr.23292. Epub 2018 Jan 30.

23.

[Integration of secondary data into national diabetes surveillance : Background, aims and results of the secondary data workshop at the Robert Koch Institute].

Schmidt C, Bätzing-Feigenbaum J, Bestmann A, Brinks R, Dreß J, Goffrier B, Hagen B, Laux G, Pollmanns J, Schröder H, Stahl T, Baumert J, Du Y, Gabrys L, Heidemann C, Paprott R, Scheidt-Nave C, Teti A, Ziese T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2017 Jun;60(6):656-661. doi: 10.1007/s00103-017-2552-7. Review. German.

PMID:
28466131
24.

Comment on: "Diabetes incidence and projections from prevalence surveys in Samoa over 1978-2013".

Hoyer A, Brinks R.

Int J Public Health. 2017 Jul;62(6):695-696. doi: 10.1007/s00038-017-0974-5. Epub 2017 Apr 27. No abstract available.

PMID:
28451723
25.

Silent progression in patients with rheumatoid arthritis: is DAS28 remission an insufficient goal in RA? Results from the German Remission-plus cohort.

Sewerin P, Vordenbaeumen S, Hoyer A, Brinks R, Buchbender C, Miese F, Schleich C, Klein S, Schneider M, Ostendorf B.

BMC Musculoskelet Disord. 2017 Apr 19;18(1):163. doi: 10.1186/s12891-017-1528-y.

26.

Comparison of surveillance-based metrics for the assessment and monitoring of disease detection: simulation study about type 2 diabetes.

Brinks R, Hoyer A, Rolka DB, Kuss O, Gregg EW.

BMC Med Res Methodol. 2017 Apr 11;17(1):54. doi: 10.1186/s12874-017-0328-2.

27.

Prospective MRI score to predict negative EULAR response in patients with rheumatoid arthritis (RA) before therapy-escalation to a biological therapy.

Sewerin P, Vordenbaeumen S, Brinks R, Ostendorf B.

Ann Rheum Dis. 2017 Nov;76(11):e44. doi: 10.1136/annrheumdis-2017-211257. Epub 2017 Mar 10. No abstract available.

PMID:
28283516
28.

Healthcare costs of Type 2 diabetes in Germany.

Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W.

Diabet Med. 2017 Jun;34(6):855-861. doi: 10.1111/dme.13336. Epub 2017 Mar 9.

PMID:
28199029
29.

Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes.

Vijayakumar P, Hoyer A, Nelson RG, Brinks R, Pavkov ME.

PLoS One. 2017 Feb 6;12(2):e0171027. doi: 10.1371/journal.pone.0171027. eCollection 2017.

30.

Need for improvements in reported cost effectiveness of adalimumab in rheumatoid arthritis.

Weber S, Pongratz G, Schneider M, Brinks R.

Z Rheumatol. 2017 Mar;76(2):183-184. doi: 10.1007/s00393-016-0255-3. No abstract available.

PMID:
28084542
31.

Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002.

Brinks R, Hoyer A, Weber S, Fischer-Betz R, Sander O, Richter JG, Chehab G, Schneider M.

Lupus Sci Med. 2016 Nov 25;3(1):e000181. eCollection 2016.

32.

Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis.

Vordenbäumen S, Lueking A, Budde P, Zucht HD, Goehler H, Brinks R, Fischer-Betz R, Richter J, Bleck E, Detert J, Langer HE, Sörgel A, Burmester GR, Schulz-Knappe P, Schneider M.

Arthritis Res Ther. 2016 Oct 12;18(1):235.

33.
34.

The Prevalence and Incidence of Diabetes in Germany.

Tamayo T, Brinks R, Hoyer A, Kuß OS, Rathmann W.

Dtsch Arztebl Int. 2016 Mar 18;113(11):177-82. doi: 10.3238/arztebl.2016.0177.

35.
36.

Development and demonstration of a state model for the estimation of incidence of partly undetected chronic diseases.

Brinks R, Bardenheier BH, Hoyer A, Lin J, Landwehr S, Gregg EW.

BMC Med Res Methodol. 2015 Nov 11;15:98. doi: 10.1186/s12874-015-0094-y.

37.

A comparative study of prevalence-based incidence estimation techniques with application to dementia data in Germany.

Landwehr S, Brinks R.

Stat Med. 2016 Feb 28;35(5):768-81. doi: 10.1002/sim.6736. Epub 2015 Sep 16.

PMID:
26376995
38.

Projected effect of increased active travel in German urban regions on the risk of type 2 diabetes.

Brinks R, Hoyer A, Kuss O, Rathmann W.

PLoS One. 2015 Apr 7;10(4):e0122145. doi: 10.1371/journal.pone.0122145. eCollection 2015.

39.

Years of life lost.

Brinks R, Hoyer A, Tamayo T, Kowall B, Rathmann W.

Dtsch Arztebl Int. 2015 Mar 20;112(12):211. doi: 10.3238/arztebl.2015.0211a. No abstract available.

40.

Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ).

Chehab G, Richter J, Sander O, Fischer-Betz R, Ostendorf B, Al-Neyadi T, Vordenbäumen S, Acar H, Brinks R, Schneider M.

Clin Exp Rheumatol. 2015 May-Jun;33(3):354-9. Epub 2015 Mar 10.

PMID:
25797042
41.

Change rates and prevalence of a dichotomous variable: simulations and applications.

Brinks R, Landwehr S.

PLoS One. 2015 Mar 6;10(3):e0118955. doi: 10.1371/journal.pone.0118955. eCollection 2015.

42.

Evaluation of a simplified version of the Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) comprising 5 joints (RAMRIS5).

Schleich C, Buchbender C, Sewerin P, Miese F, Aissa J, Brinks R, Schneider M, Antoch G, Ostendorf B.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):209-15. Epub 2015 Jan 29.

PMID:
25664925
43.

A new relation between prevalence and incidence of a chronic disease.

Brinks R, Landwehr S.

Math Med Biol. 2015 Dec;32(4):425-35. doi: 10.1093/imammb/dqu024. Epub 2015 Jan 9.

44.

Lexis diagram and illness-death model: simulating populations in chronic disease epidemiology.

Brinks R, Landwehr S, Fischer-Betz R, Schneider M, Giani G.

PLoS One. 2014 Sep 12;9(9):e106043. doi: 10.1371/journal.pone.0106043. eCollection 2014.

45.

[Gender-specific differences in capillaroscopy in healthy persons and patients with inflammatory rheumatic diseases].

Richter JG, Klein-Weigel P, Brinks R, Schneider M, Sander O.

Z Rheumatol. 2014 Sep;73(7):615-22. doi: 10.1007/s00393-014-1359-2. Review. German.

PMID:
24972749
46.

Age-specific prevalence of diagnosed systemic lupus erythematosus in Germany 2002 and projection to 2030.

Brinks R, Fischer-Betz R, Sander O, Richter JG, Chehab G, Schneider M.

Lupus. 2014 Nov;23(13):1407-11. doi: 10.1177/0961203314540352. Epub 2014 Jun 13.

PMID:
24928831
47.

Advantages of a combined rheumatoid arthritis magnetic resonance imaging score (RAMRIS) for hand and feet: does the RAMRIS of the hand alone underestimate disease activity and progression?

Sewerin P, Buchbender C, Vordenbäumen S, Scherer A, Miese F, Brinks R, Wittsack HJ, Klein S, Schneider M, Antoch G, Ostendorf B.

BMC Musculoskelet Disord. 2014 Mar 26;15:104. doi: 10.1186/1471-2474-15-104.

48.

Assessment of magnetic bead-based automated whole blood RNA-isolation from a validated RNA stabilization reagent (Tempus Blood RNA).

Vordenbäumen S, Bleck E, Brinks R, Schneider M.

J Immunol Methods. 2014 Apr;406:148-9. doi: 10.1016/j.jim.2014.02.015. Epub 2014 Mar 6. No abstract available.

PMID:
24613227
49.

Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany.

Brinks R, Landwehr S.

Theor Popul Biol. 2014 Mar;92:62-8. doi: 10.1016/j.tpb.2013.11.006. Epub 2013 Dec 10.

PMID:
24333220
50.

Validation and evaluation of the German Brief Index of Lupus Damage (BILD)--a self-reported instrument to record damage in systemic lupus erythematosus.

Chehab G, Sander O, Richter J, Acar H, Vordenbäumen S, Brinks R, Schneider M, Fischer-Betz R.

Lupus. 2013 Sep;22(10):1050-5. doi: 10.1177/0961203313500369.

PMID:
23963433

Supplemental Content

Loading ...
Support Center